GeneDx Holdings Corp.
WGS
$70.69
-$4.81-6.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.02M | 2.08M | 1.41M | -38.58M | -52.29M |
| Total Depreciation and Amortization | 24.32M | 23.00M | 22.46M | 21.48M | 21.05M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 45.57M | 31.72M | 15.67M | 28.90M | 27.48M |
| Change in Net Operating Assets | -15.60M | -23.62M | -26.50M | -13.71M | -24.75M |
| Cash from Operations | 33.28M | 33.19M | 13.02M | -1.90M | -28.50M |
| Capital Expenditure | -19.02M | -17.72M | -12.19M | -11.18M | -5.49M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -32.86M | -33.20M | -33.20M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -9.64M | -49.00K | -8.64M | -29.21M | -24.64M |
| Cash from Investing | -61.52M | -50.96M | -54.03M | -40.38M | -30.13M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.66M | -4.51M | -4.00M | -3.67M | -3.23M |
| Issuance of Common Stock | 51.69M | 60.36M | 63.05M | 61.99M | 47.39M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 48.03M | 55.86M | 59.06M | 58.32M | 44.16M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.79M | 38.08M | 18.05M | 16.03M | -14.47M |